Y
YD Bio Ltd
YDESWCIK 0002011674NasdaqNon-AcceleratedSmaller ReportingEmerging GrowthServices-Medical LaboratoriesE9KYFY ends Dec 31
Period
FY 2025
Revenue
$596.8K
Net Income
$-8.31M
Total Assets
$13.78M
Equity
$-2.86M
Shares Out
70.79M
Op. Cash Flow
$-6.60M
Business
YD Bio Ltd is a foreign private issuer in Medical Laboratories, headquartered in the Cayman Islands. Shares trade on Nasdaq under the ticker YDES.
Auto-generated from company profile
Financials
Latest annual snapshot (FY2025, period end 2025-12-31). Full statement history unavailable for this entity.
| Revenue | $596.8K |
| Net income | $-8.31M |
| Total assets | $13.78M |
| Total liabilities | $16.64M |
| Stockholders' equity | $-2.86M |
| Operating cash flow | $-6.60M |
Filings
Filing historySign up free to browse every 10-K, 10-Q, 8-K, and proxy this filer has submitted to the SEC.Sign up free · Upgrade to Pro
Material Events
Material EventsTrack every 8-K filing and material event — AI-summarized, timelined, and alertable.Sign up free · Upgrade to Pro
Insiders
Insider ActivitySee executive buy/sell windows and insider trade activity over rolling 30/90/365-day windows.Sign up free · Upgrade to Pro
Institutional Holders
Institutional HoldersSee which funds hold this stock and track position changes quarter over quarter.Sign up free · Upgrade to Pro